Related references
Note: Only part of the references are listed.Health Care Expenditures and Therapeutic Outcomes of a Pharmacist-Managed Anticoagulation Service versus Usual Medical Care
Deanne Hall et al.
PHARMACOTHERAPY (2011)
Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension
Irene Lang
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Pharmacogenomics of warfarin: Uncovering a piece of the warfarin mystery
Michael P. Gulseth et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis
Paolo Prandoni et al.
ANNALS OF INTERNAL MEDICINE (2009)
American Association of Orthopedic Surgeons and American College of Chest Physicians Guidelines for Venous Thromboembolism Prevention in Hip and Knee Arthroplasty Differ What Are the Implications for Clinicians and Patients?
John W. Eikelboom et al.
CHEST (2009)
Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Arthroplasty
Norman A. Johanson et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2009)
Heparin-induced thrombocytopenia
A. Greinacher
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Relationship between body adiposity measures and risk of primary knee and hip replacement for osteoarthritis: a prospective cohort study
Yuanyuan Wang et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Mechanisms of venous thrombosis and resolution
Thomas W. Wakefield et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Pharmacology and management of the vitamin K antagonists
Jack Ansell et al.
CHEST (2008)
Prevention of venous thromboembolism
William H. Geerts et al.
CHEST (2008)
Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty
Richard J. Friedman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Medical progress: Acute pulmonary embolism
Victor F. Tapson
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mechanisms of disease: Mechanisms of thrombus formation
Bruce Furie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Acute venous disease: Venous thrombosis and venous trauma
Mark H. Meissner et al.
JOURNAL OF VASCULAR SURGERY (2007)
Low-dose warfarin coupled with lower leg compression is effective prophylaxis against thromboembolic disease after hip arthroplasty
Murray Bern et al.
JOURNAL OF ARTHROPLASTY (2007)
Reviewing the reality: why we need to change
PJ Lin
EUROPEAN HEART JOURNAL SUPPLEMENTS (2005)
Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis
P Mismetti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement:: the EXPRESS study
BI Eriksson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement
CW Francis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study
CW Colwell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Current anticoagulant therapy - unmet clinical needs
J Hirsh
THROMBOSIS RESEARCH (2003)
Does anticoagulation do more harm than good? A comparison of patients treated without prophylaxis and patients treated with low-dose warfarin after total knee arthroplasty
RA Sachs et al.
JOURNAL OF ARTHROPLASTY (2003)
Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism
P Prandoni et al.
ANNALS OF INTERNAL MEDICINE (2002)
Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement:: the METHRO II randomised trial
B Eriksson et al.
LANCET (2002)
Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty
DR Anderson et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2002)
Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty - A randomized, double-blind trial
CW Francis et al.
ANNALS OF INTERNAL MEDICINE (2002)
Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty - A prospective controlled randomized study
P Prandoni et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery - A meta-analysis of 4 randomized double-blind studies
AGG Turpie et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Fixed minidose versus-adjusted low-dose warfarin after total joint arthroplasty - A randomized prospective study
MJ Vives et al.
JOURNAL OF ARTHROPLASTY (2001)
Prevention of venous thromboembolic disease following primary total knee arthroplasty - A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin
RH Fitzgerald et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2001)
Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: Meta-analysis based on original patient data
A Koch et al.
THROMBOSIS RESEARCH (2001)
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients -: A double-blind, randomized comparison
RD Hull et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients -: A double-blind, randomized comparison
RD Hull et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
The contrast between venographic and clinical endpoints in trials of thromboprophylaxis in hip replacement
D Warwick et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2000)
Share Paper
